ym 529 has been researched along with Hangman Fracture in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Hagino, H; Hirakawa, A; Ito, M; Matsumoto, T; Nakano, T; Soen, S; Takeuchi, T; Tanaka, S; Tanaka, Y; Yamamoto, K | 1 |
| Chen, D; Huang, X; Jin, Z; Liu, Q; Ma, T; Ye, Z | 1 |
| Hagino, H; Mori, S; Nakamura, T; Ohta, H; Sone, T; Uemura, Y | 1 |
| Fukunaga, M; Hagino, H; Miyazaki, T; Mori, S; Nakamura, T; Ohta, H; Orimo, H; Shiraki, M; Soen, S; Sone, T; Sugimoto, T; Taguchi, A; Tanaka, S; Tsukiyama, M; Uemura, Y | 1 |
| Morio, Y; Tanishima, S | 1 |
| Fukunaga, M; Hagino, H; Matsumoto, T; Nakamura, T; Nakano, T; Ohashi, Y; Shiraki, M; Takaoka, K | 1 |
| Ito, M; Kono, S; Tanaka, S; Yoshida, A | 1 |
| Abe, K; Aihara, T; Akazawa, T; Aoki, Y; Eguchi, Y; Fujimoto, K; Furuya, T; Hanaoka, E; Hirayama, J; Inage, K; Inoue, M; Ishikawa, T; Kanamoto, H; Kinoshita, H; Kinoshita, T; Koda, M; Kotani, T; Kubota, G; Murata, Y; Nemoto, T; Ohtori, S; Orita, S; Sainoh, T; Sakuma, T; Sato, J; Shiga, Y; Suseki, K; Suzuki, M; Takahashi, K; Yamagata, M; Yamashita, M; Yamauchi, K | 1 |
| Fukunaga, M; Hagino, H; Matsumoto, T; Morii, H; Nakamura, T; Nakano, T; Ohashi, Y; Shiraki, M; Takaoka, K | 1 |
| Hagino, H | 2 |
| Aoyama, K; Kimoto, A; Minamide, T; Miyata, K; Mori, H; Mori, M; Nozaki, K; Sasamata, M; Shimizu, K; Shimokawa, K; Suzuki, H; Tanaka, M; Usui, T; Yamamotoya, H | 1 |
| Miki, T; Minamide, T | 1 |
6 review(s) available for ym 529 and Hangman Fracture
| Article | Year |
|---|---|
Minodronate in the treatment of osteoporosis: A systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Bone Density Conservation Agents; Case-Control Studies; Collagen Type I; Creatinine; Diphosphonates; Drug Therapy, Combination; Female; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risedronic Acid; Spinal Fractures; Tartrate-Resistant Acid Phosphatase; Treatment Outcome; Vitamin D | 2020 |
A review of minodronic acid hydrate for the treatment of osteoporosis.
Topics: Aged; Aged, 80 and over; Aging; Biomarkers; Bone Density; Bone Density Conservation Agents; Delayed-Action Preparations; Diphosphonates; Female; Fractures, Bone; Humans; Imidazoles; Incidence; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Spinal Fractures | 2013 |
[New development in bisphosphonate treatment. Review of the preventive effect of minodronic acid on fracture in Japanese patients with osteoporosis].
Topics: Aged; Aged, 80 and over; Asian People; Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Diphosphonates; Female; Fractures, Spontaneous; Humans; Imidazoles; Middle Aged; Risk; Spinal Fractures | 2009 |
Pharmacological profile and clinical efficacy of minodronic acid hydrate as a new therapeutic agent for osteoporosis.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Geranyltranstransferase; GTP-Binding Proteins; Humans; Imidazoles; Mevalonic Acid; Osteoporosis; Spinal Fractures | 2009 |
[Minodronic acid- its clinical efficacy and prospects for once-a-month dosing regimen].
Topics: Administration, Oral; Clinical Trials as Topic; Diphosphonates; Drug Administration Schedule; Female; Fractures, Spontaneous; Humans; Imidazoles; Osteoporosis, Postmenopausal; Patient Compliance; Quality of Life; Risk; Spinal Fractures; Time Factors | 2011 |
[Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate].
Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Female; Humans; Imidazoles; Osteoclasts; Osteoporosis; Rats; Spinal Fractures | 2007 |
7 trial(s) available for ym 529 and Hangman Fracture
| Article | Year |
|---|---|
Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxycholecalciferols; Imidazoles; Male; Middle Aged; Osteoporosis; Spinal Fractures; Young Adult | 2020 |
Risk factors for incident vertebral fractures in osteoporosis pharmacotherapy: a 2-year, prospective, observational study.
Topics: Accidental Falls; Aged; Biomarkers; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Multivariate Analysis; Osteoporosis; Prevalence; Prospective Studies; Raloxifene Hydrochloride; Risk Factors; Spinal Fractures | 2021 |
Study design of multi-center, open-label randomized controlled, head-to-head trial comparing minodronic acid and raloxifene: Japanese Osteoporosis Intervention Trial (JOINT)-04.
Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Incidence; Osteoporotic Fractures; Raloxifene Hydrochloride; Sample Size; Spinal Fractures | 2019 |
Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Middle Aged; Osteoporosis; Spinal Fractures | 2013 |
Effectiveness of monotherapy and combined therapy with calcitonin and minodronic acid hydrate, a bisphosphonate, for early treatment in patients with new vertebral fractures: An open-label, randomized, parallel-group study.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Imidazoles; Lumbar Vertebrae; Male; Osteoporosis; Retrospective Studies; Spinal Fractures; Time Factors; Time-to-Treatment; Treatment Outcome | 2017 |
The nature of osteoporotic low back pain without acute vertebral fracture: A prospective multicenter study on the analgesic effect of monthly minodronic acid hydrate.
Topics: Aged; Aged, 80 and over; Diphosphonates; Drug Administration Schedule; Female; Humans; Imidazoles; Low Back Pain; Male; Osteoporosis; Pain Measurement; Prospective Studies; Spinal Fractures; Treatment Outcome | 2017 |
Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Biomarkers; Body Height; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Double-Blind Method; Drug Administration Schedule; Female; Fractures, Bone; Humans; Imidazoles; Middle Aged; Osteoporosis, Postmenopausal; Spinal Fractures; Treatment Outcome | 2009 |